Zhang Jianhua, Niu Dandan, Sui Jianjun, Ching Chi Bun, Chen Wei Ning
School of Chemical and Biomedical Engineering, Nanyang Technological University, 62 Nanyang Drive, Singapore.
Proteomics. 2009 May;9(10):2836-45. doi: 10.1002/pmic.200800911.
Hepatitis B virus (HBV) infection and in particular Hepatitis B Virus X Protein have been shown to modulate angiogenesis. However, a comprehensive and coordinated mechanism in the HBV-induced angiogenesis remains to be established. In this study, transient transfection of replicative HBV genome was carried out in rat primary hepatocytes (RPHs) as well as HepG2 cells. Angiogenesis was assessed by tube formation assay. 2-D LC-MS/MS analysis was used to detect differentially expressed proteins in cells, supporting HBV replication compared with those transfected with the empty vector. A cell-based HBV replication was established in both RPHs and HepG2 cells. HBV replication-induced angiogenesis was indicated by tube formation of endothelial cells cultured in condition medium from RPHs or HepG2 cells supporting HBV replication. Enzymes associated with angiogenesis, namely fumarate hydratase and tryptophanyl-tRNA synthetase, were identified by 2-D LC-MS/MS analysis in HBV replicating RPHs and HepG2 cells. Our results indicated that the application of quantitative proteomics based on iTRAQ can be an effective approach to evaluate the effects of HBV replication on liver angiogenesis. The angiogenesis-associated proteins identified in our study may eventually lead to novel anti-angiogenic hepatocellular carcinoma cancer therapy based on tumor vascular targeting or be the markers for hepatocellular carcinoma diagnosis.
乙型肝炎病毒(HBV)感染,尤其是乙型肝炎病毒X蛋白,已被证明可调节血管生成。然而,HBV诱导血管生成的全面协调机制仍有待确立。在本研究中,在大鼠原代肝细胞(RPHs)以及HepG2细胞中进行了复制性HBV基因组的瞬时转染。通过管腔形成试验评估血管生成。二维液相色谱-串联质谱(2-D LC-MS/MS)分析用于检测与空载体转染细胞相比,支持HBV复制的细胞中差异表达的蛋白质。在RPHs和HepG2细胞中均建立了基于细胞的HBV复制。在支持HBV复制的RPHs或HepG2细胞的条件培养基中培养的内皮细胞的管腔形成表明HBV复制诱导了血管生成。通过二维液相色谱-串联质谱分析在HBV复制的RPHs和HepG2细胞中鉴定出与血管生成相关的酶,即延胡索酸水合酶和色氨酸-tRNA合成酶。我们的结果表明,基于iTRAQ的定量蛋白质组学应用可能是评估HBV复制对肝脏血管生成影响的有效方法。我们研究中鉴定出的血管生成相关蛋白最终可能导致基于肿瘤血管靶向的新型抗血管生成肝细胞癌治疗方法,或成为肝细胞癌诊断的标志物。